RDHL - レッドヒル・バイオファ―マ (Redhill Biopharma Ltd.)

RDHLのニュース

   RedHill's Oncology Candidate to be Tested for Coronavirus  2020/04/21 16:19:00 Zacks Investment Research
RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Stock up.
   RedHill (RDHL) Soars: Stock Adds 9.2% in Session  2020/04/15 12:44:00 Zacks Investment Research
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill (RDHL) Soars: Stock Adds 9.2% in Session  2020/04/15 12:44:00 Zacks Investment Research
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill Biopharma buys rights to Movantik from AstraZeneca  2020/02/25 13:09:40 Seeking Alpha
RedHill Biopharma (NASDAQ:RDHL) says it is acquiring the global rights to Movantik (naloxegol), a peripherally acting mu-opioid receptor antagonist indicat
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill Biopharma buys rights to Movantik from AstraZeneca  2020/02/25 13:09:40 Seeking Alpha
RedHill Biopharma (NASDAQ:RDHL) says it is acquiring the global rights to Movantik (naloxegol), a peripherally acting mu-opioid receptor antagonist indicat
   RedHill Biopharma to Discontinue Promotion of Legacy Products  2020/01/21 14:14:42 Investing News Network
RedHill Biopharma is discontining its commercialization agreements for its legacy products and focusing on its lead commercial products. The post RedHill Biopharma to Discontinue Promotion of Legacy Products appeared first on Investing News Network .

calendar